A+ A A-


National Cancer Institute

Tagged under:

NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.

Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institute, National Institutes of Health

A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.

Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer

Overall cancer death rates continued to fall among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.

Monica Bertagnolli begins work as 16th director of the National Cancer Institute

Monica M. Bertagnolli, M.D., begins her tenure as the 16th director of the National Cancer Institute on October 3, 2022. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.

A healthy lifestyle may help former smokers lower their risk of death from all causes

A new study finds that former smokers who stick to a healthy lifestyle have a lower risk of dying from all causes, including cancer and heart and lung disease, than those who don’t have healthy habits.

In primo piano